These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 156065)

  • 1. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.
    Houghton JA; Houghton PJ; Wooten RS
    Cancer Res; 1979 Jul; 39(7 Pt 1):2406-13. PubMed ID: 156065
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
    Gelijkens CF; Sandra P; Belpaire F; De Leenheer AP
    Drug Metab Dispos; 1980; 8(5):363-6. PubMed ID: 6107236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of thymidine after administration of fluorouracil and fluorouridine to adult and embryo mice.
    Williams JP
    Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):859-68. PubMed ID: 4264748
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
    el Hag IA; Roos G; Jönsson PE; Stenram U
    Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
    Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
    Jato JG; Lake LM; Grunden EE; Johnson BM
    J Pharm Sci; 1975 Jun; 64(6):943-6. PubMed ID: 124347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosidic bond cleavage of 5-fluoro-2'-deoxyuridine and 5-fluorouridine by amino acyl-tRNA synthetases.
    Kumar AM; Nayak R
    Biochem Biophys Res Commun; 1990 Dec; 173(2):731-5. PubMed ID: 2148086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
    Pizzorno G; Wiegand RA; Lentz SK; Handschumacher RE
    Cancer Res; 1992 Apr; 52(7):1660-5. PubMed ID: 1551097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The embryotoxic effects of 5-fluoro-2'-deoxyuridine in mice.
    Kleinbrecht J
    Teratology; 1970 Nov; 3(4):315-8. PubMed ID: 4282423
    [No Abstract]   [Full Text] [Related]  

  • 14. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice.
    Harrison SD; Denine EP; Peckham JC
    Cancer Treat Rep; 1978 Apr; 62(4):533-45. PubMed ID: 657150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells.
    Inaba M; Mitsuhashi J
    Oncol Res; 1994; 6(7):303-9. PubMed ID: 7865905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
    Houghton JA; Houghton PJ
    Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD; Wallace HJ; Diasio RB
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of cytotoxicity of 5-fluorouracil: distinction between the irreversible cytotoxic effect of 5-fluorouridine and the reversible cytotoxic effect of 5-fluoro-2'-deoxyuridine on murine lymphoma L5178Y cells in culture.
    Kanzawa F; Hoshi A; Kuretani K
    J Cancer Res Clin Oncol; 1980; 98(1):85-90. PubMed ID: 6450213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased immunosuppression associated with antitumor activity of 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine.
    Connolly KM; Diasio RB; Armstrong RD; Kaplan AM
    Cancer Res; 1983 Jun; 43(6):2529-35. PubMed ID: 6221793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.